Financhill
Back

Deckers Outdoor Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
45

DECK
Deckers Outdoor

Last Price:
$121.56
Seasonality Move:
10.13%
Buy
54

SRPT
Sarepta Therapeutics

Last Price:
$99.80
Seasonality Move:
6.73%
Sell
45
Deckers Outdoor (DECK) is a Sell

Is Deckers Outdoor a Buy, Sell or Hold?

  • The current Deckers Outdoor [DECK] share price is $121.58. The Score for DECK is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DECK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $100.71. The Score for SRPT is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DECK Stock Price Chart

What is Deckers Outdoor's stock price today?

  • The Deckers Outdoor share price today is $121.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DECK is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $100.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

DECK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -15.49 Sell
Relative Strength Index (14 RSI): 21.3 Sell
Chaikin Money Flow: -2748288 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (133.31 - 164.13) Sell
Bollinger Bands (100): (153.79 - 206.91) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.22 Sell
Relative Strength Index (14 RSI): 38.38 Sell
Chaikin Money Flow: 544784 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

DECK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 130.9 Sell
20-day SMA: 143.25 Sell
50-day SMA: 178.73 Sell
200-day SMA: 169.09 Sell
8-day EMA: 130.12 Sell
20-day EMA: 144.35 Sell
50-day EMA: 165.2 Sell
200-day EMA: 165.69 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.91 Sell
20-day SMA: 106.68 Sell
50-day SMA: 114.29 Sell
200-day SMA: 126.68 Sell
8-day EMA: 104.06 Sell
20-day EMA: 106.89 Sell
50-day EMA: 112.29 Sell
200-day EMA: 121 Sell

Deckers Outdoor Earnings Growth & DECK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, a decrease next quarter of $2.49 per share, an increase this year of $1.37 per share, and an increase next year of $0.75 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Deckers Outdoor Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):